Archive for the 'Uncategorized' Category

Completion of Enrollment in XPAND US Trial

Apr 14, 2015by admin

PALO ALTO, Calif., April 14, 2015 /PRNewswire/ — AirXpanders Inc., a company developing novel technology for women who require tissue expansion for breast reconstruction following a mastectomy, today announced that it has completed the targeted enrollment of 150 subjects in the company’s U.S.-based, multi-center, prospective, randomized, controlled, open-label pivotal study of the AeroForm® patient-controlled tissue expander. […]

Read More

PRS Journal Presents PACE 2 Interim Results

Nov 07, 2014by admin

Patient-Activated Controlled Expansion (PACE) for Breast Reconstruction Utilizing Controlled Carbon Dioxide Inflation: Confirmation of aFeasibility Study Tony F. Connell, MBBS, BSc, FRACS Subiaco, Western Australia, Australia Interim results from the study described in this paper have been presented at the 17th World Congress of the International Confederation for Plastic, Reconstructive and Aesthetic Surgery, Santiago, Chile, […]

Read More

ASPIRE Study Results

Nov 07, 2014by admin

Results from the ASPIRE Study for Breast Reconstruction Utilizing the AeroForm™ Controlled Carbon Dioxide-Inflated Tissue Expanders Tony F. Connell, MBBS, BSc, FRACS Subiaco, Western Australia, Australia CORRESPONDING AUTHOR CONTACT INFORMATION Tony F. Connell, MBBS, BSc, FRACS 3/200 Rokeby Road Subiaco 6008 WA Australia Email: phatconw@iinet.net.au Facsimile: 011-9382-4944 Office: 011-9382-4844 FINANCIAL DISCLOSURE AND PRODUCTS Disclosure: Mr. […]

Read More

AirXpanders Clinical Data on Radiation Therapy

Nov 03, 2014by admin

Presentations include the latest interim results from XPAND head-to-head pivotal study and data on whether AeroForm-implanted patients can undergo radiation therapy for residual breast cancer while completing the expansion process PALO ALTO, Calif., Oct. 6, 2014 /PRNewswire/ — The latest interim data from XPAND, AirXpanders Inc.’s U.S.-based, head-to-head pivotal study of its new, needle-free, patient-controlled […]

Read More

AeroForm Radiation Study Results

Jun 18, 2014by admin

 New Published Study Shows That Radiation Can Be Delivered to Target Tissue Through the AeroForm™ Patient-Controlled Breast Tissue Expander Results indicate that breast cancer patients can receive adequate doses of radiation therapy while undergoing patient-controlled tissue expansion as part of the breast reconstruction process Results published in the June 2014 issue of Practical Radiation Oncology […]

Read More

AirXpanders XPAND Trial Interim Results

Apr 16, 2014by admin

Interim Results of AirXpanders’ Multi-Centered Randomized Controlled Trial Demonstrate Faster, Needle-Free Alternative to Saline Tissue Expanders   Highly statistically significant improvement in expansion and total implant times compared to saline Interim results of the XPAND trial published in the April 2014 issue of Plastic and Reconstructive Surgery   PALO ALTO, Calif., April 15, 2014 /PRNewswire/ […]

Read More

AirXpanders Secures $7 million from GE Capital

Apr 16, 2014by admin

AirXpanders Secures $7 million Senior Secured Credit Facility from GE Capital   Credit facility to support completion of AeroForm™ U.S. pivotal trial and pre-commercialization activities BETHESDA, Md. and  PALO ALTO, Calif. (April 2, 2014) – AirXpanders Inc., a company developing an alternative technology for women who require tissue expansion for breast reconstruction following a mastectomy, […]

Read More

AeroForm Approved in Australia

Nov 13, 2013by admin

World’s First Needle-Free, Patient-Controlled Tissue Expansion Device for Women Undergoing Breast Reconstruction Following Mastectomy Approved in Australia  Australia represents the first commercial market for AirXpanders’s AeroForm®  Company to launch AeroForm to select plastic surgeons  PALO ALTO, Calif. (November 4, 2013) – AirXpanders Inc., a company developing novel technology for women who require tissue expansion for […]

Read More

Studies Show Radiation Therapy Does not Affect Mechanism in AeroForm

Nov 13, 2013by admin

AirXpanders Data Shows Radiation Therapy After Mastectomy Does Not Affect Mechanism in AeroForm™ Expander PALO ALTO, Calif. (October 28, 2013) – AirXpanders Inc., a company developing novel technology for women who require tissue expansion for breast reconstruction following a mastectomy, today announced new data published in The Journal of Radiation Oncology that demonstrates the AeroForm™ […]

Read More

European CE Mark Approval for AeroForm

Nov 14, 2012by admin

AirXpanders Announces European CE Mark Approval for AeroForm™ Patient-Controlled Tissue Expander for Patients Undergoing Breast Reconstruction PALO ALTO, Calif. (Oct 25, 2012) – AirXpanders Inc., a company developing novel technology for women who require tissue expansion for breast reconstruction following a mastectomy, today announced that it has received European CE Mark approval for AeroForm™, a […]

Read More